Intrathecal 2-hydroxypropyl-�-cyclodextrin Decreases Neurological Disease Progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial
Lancet 390:1758-1768, Ory, D.S.,et al, 2017
Course and Outcome of Acute Cerebellar Ataxia
Ann Neurol 35:673-679, Connolly,A.M.,et al, 1994